Stroopinsky, Dina <br/><br/>
Rituximab-induced direct inhibition of T-cell activation.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Aug 2012 
 - 1233-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-011-1168-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Cell Separation<br/>Cytokines--biosynthesis<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Lymphocyte Activation--drug effects<br/>Lymphocyte Culture Test, Mixed<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Rituximab<br/>T-Lymphocytes--drug effects